Back to results
US 7,925,351 B2Granted
Gastrointestinal device for treating obesity and diabetes
AssigneeBetastim, Ltd.
InventorsRadwan Khawaled, Jacob Benarie, Yossi Gross
Life of this patent
Estimating the term…
Abstract
Apparatus is provided, including an ingestible capsule, one or more electrodes coupled to the capsule, and a control unit configured to maintain the capsule in a vicinity of a designated site of a subject by driving at least a subset of the electrodes to apply a current that induces reverse intestinal peristalsis in the subject. Other embodiments are also described.
Claims82
Apparatus, comprising:
- an ingestible capsule;
- one or more electrodes coupled to the capsule;
- and
- a control unit configured to maintain the capsule in a vicinity of a designated site of a subject by driving at least a subset of the electrodes to apply a current that induces reverse intestinal peristalsis in the subject.
1 more element
Apparatus, comprising:
- one or more implantable electrodes configured to be implanted at a sphincter of Oddi of a subject;
- and
- a control unit, configured to drive the electrodes to apply a current that induces contraction of the sphincter of Oddi.
A method, comprising:
- inducing reverse intestinal peristalsis in a subject by electrical stimulation;
- and
- configuring the stimulation to maintain an ingestible capsule in a vicinity of a pyloric sphincter of the subject.
A method, comprising:
- inducing reverse intestinal peristalsis in a subject by electrical stimulation;
- and
- configuring the stimulation to maintain an ingestible capsule in a vicinity of a sphincter of Oddi of the subject.
A method, comprising:
- inducing reverse intestinal peristalsis in a subject by electrical stimulation;
- and
- configuring the stimulation to maintain an ingestible capsule in a segment of the small intestine surrounding a pancreas of the subject.
Dependencies are inferred from the claim text.